Treatment of Genotype 1 HCV Infection in the HIV Coinfected Patient in 2014

被引：0
|
作者：
Cody A. Chastain
Susanna Naggie
机构：
[1] Vanderbilt University Medical Center,Division of Infectious Diseases
[2] Division of Infectious Diseases,undefined
[3] Duke Clinical Research Institute,undefined
来源：
Current HIV/AIDS Reports | 2013年 / 10卷
关键词：
Hepatitis C; HIV; HIV-HCV coinfection; Telaprevir; Boceprevir; Sofosbuvir; Simeprevir; Faldaprevir; Daclatasvir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Hepatitis C (HCV) coinfection is the leading cause of liver-related morbidity and is a leading cause of mortality in human immunodeficiency virus (HIV)-infected individuals in the antiretroviral therapy era. Direct-acting antiviral (DAA) therapies are transforming how HCV is treated with significant improvements in efficacy and tolerability. In this article, DAA agents expected to be available in 2014 are reviewed, including telaprevir, boceprevir, sofosbuvir, simeprevir, faldaprevir, and daclatasvir. Available data regarding clinical efficacy, adverse effects, and drug interactions in HIV-HCV coinfection are discussed. The management of adverse effects of HCV therapy and treatment considerations in patients with cirrhosis are also reviewed.
引用
收藏
页码：408 / 419
页数：11
相关论文
共 50 条
  • [41] Influence of the HIV GWG variant in the HIV infection progression in mono and HCV coinfected patients
    Hebeler-Barbosa, Flavia
    Massolini, Viviam Milanez
    Watanabe, Thais
    Silva, Giovanni Faria
    Barbosa, Alexandre Naime
    Simoes, Rafael Plana
    Ferrasi, Adriana Camargo
    de Andrade Zanotto, Paolo Marinho
    de Moura Campos Pardini, Maria Ines
    Tommasini Grotto, Rejane Maria
    MEDICINE, 2019, 98 (29) : e16376
  • [42] INCREASING INCIDENCE OF CANCER IN PERSONS LIVING WITH HIV COINFECTED WITH HCV: AN ADDITIONAL IMPACT OF HCV INFECTION?
    Mena, A.
    Meijide, H.
    Rodriguez-Osorio, I.
    Castro-Iglesias, A.
    Pertega, S.
    Rodriguez-Martinez, G.
    Pernas, B.
    Balinas, J.
    Pedreira, J. D.
    Poveda, E.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S607 - S607
  • [43] Higher frequency of occult HCV infection in HIV/HCV coinfected patients with advanced liver disease: Post DAAs treatment observation
    Bagaglio, Sabrina
    Messina, Emanuela
    Vercesi, Riccardo
    Morsica, Giulia
    Salpietro, Stefania
    Bigoloni, Alba
    Della Torre, Liviana
    Concetta, Vinci
    Lazzarin, Adriano
    Uberti-Foppa, Caterina
    Hasson, Hamid
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E726 - E727
  • [44] Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients
    Miailhes, Patrick
    Gilbert, Camille
    Lacombe, Karine
    Arends, Joop E.
    Puoti, Massimo
    Rockstroh, Jurgen K.
    Sogni, Philippe
    Fontaine, Helene
    Rosenthal, Eric
    Winnock, Maria
    Loko, Marc-Arthur
    Wittkop, Linda
    Dabis, Francois
    Salmon, Dominique
    LIVER INTERNATIONAL, 2015, 35 (09) : 2090 - 2099
  • [45] Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases
    Maida, Ivana
    Soriano, Vincent
    Barreiro, Pablo
    Rivas, Pablo
    Labarga, Pablo
    Nunez, Marina
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2007, 23 (06) : 801 - 804
  • [46] HCV quasispecies complexity is related to CD4 cell count and HCV genotype in HIV coinfected patients
    Afonso, AR
    Robain, M
    Simmoneau, D
    Rodriguez-Mathieu, P
    Gigou, M
    Mayer, L
    Dussaix, E
    JOURNAL OF HEPATOLOGY, 2001, 34 : 137 - 137
  • [47] Improved Treatment for Primary HIV Infection by Interferon-Alfa Therapy? Does HCV Treatment in HIV/HCV Coinfected Patients Help Us to Test This Hypothesis? Reply
    Azzoni, Livio
    Foulkes, Andrea S.
    Papasavvas, Emmanouil
    Mexas, Angela M.
    Lynn, Kenneth M.
    Mounzer, Karam
    Tebas, Pablo
    Jacobson, Jeffrey M.
    Frank, Ian
    O'Doherty, Una
    Kostman, Jay
    Montaner, Luis J.
    JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (02): : 363 - 363
  • [48] GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: Importance of the GBV-C genotype
    Schwarze-Zander, Carolynne
    Blackard, Jason T.
    Zheng, Hui
    Addo, Marylyn M.
    Lin, Wenyu
    Robbins, Gregory K.
    Sherman, Kenneth E.
    Zdunek, Dietmar
    Hess, Georg
    Chung, Raymond T.
    JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (04): : 410 - 419
  • [49] Is response to anti-HCV treatment predictive of mortality in HCV/HIV coinfected people?
    Berenguer, Juan
    FUTURE VIROLOGY, 2016, 11 (04) : 245 - 248
  • [50] HCV treatment with direct-acting antivirals (DAAs) in HIV/HCV coinfected subjects affects the dynamics of the HIV-1 reservoir
    Ghiglione, Y.
    Polo, M. L.
    Solomon, A.
    Poblete, G.
    Rolon, M. J.
    Patterson, P.
    Perez, H.
    Salomon, H.
    Quiroga, F.
    Turk, G.
    Lewin, S. R.
    Laufer, N.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 95 - 95
12345